Search

Search Constraints

You searched for: Author/Creator Dudda, Milena

Search Results

1. Hematological immune related adverse events after treatment with immune checkpoint inhibitors. (April 2021)

2. Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature. Issue 1 (23rd November 2020)

3. Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature. Issue 1 (February 2021)

4. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. Issue 5 (13th May 2021)